Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Articles|March 27, 2025
April Issue of Patient Care Digital Edition is Now Live
Author(s)Sydney Jennings
The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.
Advertisement
The latest issue of the Patient Care© digital edition is now
This month's issue offers primary care physicians key insights into atopic dermatitis management. Highlights include:
- A featured discussion between dermatologist Omar Noor, MD, and pediatrician Randy Alevi, DO, emphasizing the importance of early diagnosis in primary care settings.
- A review of recently FDA-approved nonsteroidal topical therapies, such as roflumilast, ruxolitinib, and tapinarof.
- Insights from recent dermatology conferences, including the 2025 American Academy of Dermatology Annual
Meeting and the 22nd Annual Winter Clinical
Dermatology Conference – Hawaii.
Find out more in the digital edition,
Advertisement
Related to this article
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
3
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
4
Lyme Seropositivity Linked to Tick-Borne Co-Exposure in US Laboratory Study
5